Lates News

Aclaris Therapeutics(ACRS.US): The Q1 financial report for 2025 achieved revenue of 1.455 million US dollars, down from 2.398 million US dollars, with an expected value of 4.78 million US dollars. Earnings per share were -0.12 US dollars, down from -0.24 US dollars, with an expected value of -0.12 US dollars.